Pan-Cancer Analysis of BUB1B/hsa-miR-130a-3p Axis and Identification of Circulating hsa-miR-130a-3p as a Potential Biomarker for Cancer Risk Assessment

<div>Correlations between the BUB1B and hsa-miR-130a-3p expression and the main pathological stages, including stage I, stage II, stage III, and stage IV.</div>

Evidence-Based Complementary and Alternative Medicine

fig9

Figure 9

Figure 9: Pan-Cancer Analysis of BUB1B/hsa-miR-130a-3p Axis and Identification of Circulating hsa-miR-130a-3p as a Potential Biomarker for Cancer Risk Assessment 

Figure 9 | Pan-Cancer Analysis of BUB1B/hsa-miR-130a-3p Axis and Identification of Circulating hsa-miR-130a-3p as a Potential Biomarker for Cancer Risk Assessment 